3D-printed distal caps are as efficient and safe as commercial caps during ESD, while providing superior visibility, scope control, and tissue traction.
Does a 3D-printed distal cap provide noninferior efficiency and safety compared to a commercial cap during ex vivo ESD?
Customizable 3D-printed distal caps are a safe, efficient, and potentially cost-effective alternative to commercial caps for ESD training and practice, offering superior scope control and visibility in ex vivo models.
The ENDOPRINT trial demonstrated that a 3D-printed distal cap is as efficient and safe as a commercial cap during ESD, while providing superior visibility, scope control, and tissue traction. These results support the potential of customizable 3D-printed accessories with substantially lower per-unit material costs compared to commercial devices for clinical practice and training, warranting further in vivo validation and formal cost-effectiveness studies.
Jan et al. (2026) studied this question. 3D-printed distal caps are as efficient and safe as commercial caps during ESD, while providing superior visibility, scope control, and tissue traction.